List of works - Carlos Pérez-Sánchez

AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.

scientific article published on 7 April 2010

Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis.

scientific article

Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment

scientific article published on 21 March 2014

Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions

scientific article

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα

scientific article

Circulating microRNAs as Potential Biomarkers of Disease Activity and Structural Damage in Ankylosing Spondylitis Patients.

scientific article published on 10 January 2018

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome.

scientific article published on 15 March 2018

Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus

scientific article

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.

scientific article published on 20 December 2010

Human mesenchymal stromal cell lysates as a novel strategy to recover liver function

scientific article published in January 2015

Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.

scientific article

Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment

scientific article published on 23 April 2012

Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens.

scientific article published on 27 February 2017

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.

scientific article

Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial

scientific article

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways

scientific article published on 23 August 2018

miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease

scientific article published on 01 April 2022

List of works by Carlos Pérez-Sánchez

AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.

Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis.

Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment

Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα

Circulating microRNAs as Potential Biomarkers of Disease Activity and Structural Damage in Ankylosing Spondylitis Patients.

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome.

Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.

Human mesenchymal stromal cell lysates as a novel strategy to recover liver function

Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.

Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment

Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens.

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.

Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways

miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease